agilon health, inc. (AGL)

agilon health Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	5,874	6,048	4,307	2,385	1,518	1,214
Other Revenue	11.97	12.82	9.01	3.33	3.17	4.06
Revenue	5,886	6,061	4,316	2,388	1,521	1,218
Revenue Growth (YoY)	5.21%	40.41%	80.74%	56.96%	24.88%	53.36%
Cost of Revenue	5,993	6,056	4,247	2,277	1,456	1,124
Gross Profit	-107.61	4.84	69.67	111.36	65.74	94.15
Selling, General & Admin	233.61	264.34	285.57	205.32	422.1	137.29
Operating Expenses	261.73	288.8	301.62	214.27	432.59	150.82
Operating Income	-369.34	-283.96	-231.95	-102.91	-366.84	-56.67
Interest Expense	-6.5	-6.18	-6.66	-4.48	-6.15	-8.14
Interest & Investment Income	16	19.2	27.9	14.5	-	-
Earnings From Equity Investments	28.52	14.99	16.49	10.72	-6.77	0.51
Other Non Operating Income (Expenses)	18.28	15.29	-0.06	-0.57	2.18	1.95
EBT Excluding Unusual Items	-313.04	-240.65	-194.27	-82.74	-377.58	-62.34
Asset Writedown	-3.6	-3.6	-	-	-	-
Other Unusual Items	-4.58	-4.58	-0.19	-7.93	-5.4	-
Pretax Income	-321.21	-248.83	-194.46	-90.67	-382.98	-62.34
Income Tax Expense	1.68	1.45	0.79	1.64	0.89	0.87
Earnings From Continuing Operations	-322.9	-250.28	-195.25	-92.31	-383.86	-63.21
Earnings From Discontinued Operations	14.64	-9.82	-67.55	-14.55	-22.93	3.16
Net Income to Company	-308.26	-260.1	-262.8	-106.86	-406.79	-60.05
Minority Interest in Earnings	-	-0.05	0.21	0.31	0.3	-
Net Income	-308.26	-260.15	-262.6	-106.55	-406.49	-60.05
Net Income to Common	-308.26	-260.15	-262.6	-106.55	-406.49	-60.05
Shares Outstanding (Basic)	413	411	409	408	373	323
Shares Outstanding (Diluted)	413	411	409	408	373	323
Shares Change (YoY)	1.35%	0.50%	0.19%	9.45%	15.29%	9.75%
EPS (Basic)	-0.75	-0.63	-0.64	-0.26	-1.09	-0.19
EPS (Diluted)	-0.75	-0.63	-0.65	-0.26	-1.09	-0.19
Free Cash Flow	-82.35	-71.03	-172.03	-146.23	-154.72	-54.98
Free Cash Flow Per Share	-0.20	-0.17	-0.42	-0.36	-0.41	-0.17
Gross Margin	-1.83%	0.08%	1.61%	4.66%	4.32%	7.73%
Operating Margin	-6.28%	-4.69%	-5.37%	-4.31%	-24.11%	-4.65%
Profit Margin	-5.24%	-4.29%	-6.08%	-4.46%	-26.72%	-4.93%
Free Cash Flow Margin	-1.40%	-1.17%	-3.99%	-6.12%	-10.17%	-4.51%
EBITDA	-341.22	-259.49	-215.9	-93.96	-356.36	-43.14
EBITDA Margin	-5.80%	-4.28%	-5.00%	-3.93%	-23.42%	-3.54%
D&A For EBITDA	28.12	24.46	16.04	8.95	10.48	13.53
EBIT	-369.34	-283.96	-231.95	-102.91	-366.84	-56.67
EBIT Margin	-6.28%	-4.69%	-5.37%	-4.31%	-24.11%	-4.65%
Revenue as Reported	5,886	6,061	4,316	2,388	1,521	1,218

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q